Concepedia

Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial

Guy de Bruyn, David Gordon, Theodore S. Steiner, Paul Anantharajah Tambyah, Catherine Cosgrove, Mark G. Martens, Ehab Bassily, Eng-Soon Chan, Dhaval M. Patel, Josh Chen,

The Lancet Infectious Diseases · 2020 · 77 citations · 18 references

DOI

Concepts

References

18

Changes in Prevalence of Health Care–Associated Infections in U.S. Hospitals

Shelley S. Magill, Erin O’Leary, Sarah J. Janelle et al. · New England Journal of Medicine · 2018 · 1.2K citations · Full text

, , +10

Asymptomatic Carriage of<i>Clostridium difficile</i>and Serum Levels of IgG Antibody against Toxin A

Lorraine Kyne, Michel Warny, Amir Qamar et al. · New England Journal of Medicine · 2000 · 935 citations · Full text

, , +13

Bezlotoxumab for Prevention of Recurrent <i>Clostridium difficile</i> Infection

Mark H. Wilcox, Dale N. Gerding, Ian R. Poxton et al. · New England Journal of Medicine · 2017 · 850 citations · Full text

, , +14

Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea

Lorraine Kyne, Michel Warny, Amir Qamar et al. · The Lancet · 2001 · 802 citations

, , +14

Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease

Lynne V. McFarland, Gary W. Elmer, Christina M. Surawicz · The American Journal of Gastroenterology · 2002 · 722 citations

, , +7